Osaic Holdings’s Annovis Bio ANVS Stock Holding History
Bought
Maintained
Sold
Other funds holding ANVS
VCM
VFT
MFG
Osaic Holdings's ANVS Position: Q1 2026 in Review
Osaic Holdings reduced its Annovis Bio (ANVS) stake by 95% in Q1 2026, selling an estimated $548 and leaving 10 shares worth $22. The position accounts for ﹤0.01% of the portfolio, ranked #7714.
Osaic Holdings first reported a position in ANVS in Q1 2020 and has held it in 25 quarters since. The position peaked at $349K in Q3 2021. 56 funds tracked by Wall St. Rank hold ANVS as of Q1 2026.
- Osaic Holdings held 10 shares of Annovis Bio worth $22 as of Q1 2026.
- Osaic Holdings sold 200 Annovis Bio shares in Q1 2026, an estimated $548.
- Annovis Bio made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7714 holding.
- Osaic Holdings first reported a position in Annovis Bio in Q1 2020 and has held it in 25 quarters since.
- Osaic Holdings's Annovis Bio position peaked at $349K in Q3 2021.
- 56 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2026.
Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.